Point72 Hong Kong’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-16,377	Closed	-$3.5M	–	2003
2022 Q2	$3.5M	Buy	16,377 +14,089	+616%	+$3.44M	0.23%	203
2022 Q1	$650K	Buy	2,288 +1,521	+198%	+$469K	0.06%	638
2021 Q4	$289K	Buy	767 +516	+206%	+$200K	0.02%	912
2021 Q3	$104K	Buy	+251	New	+$104K	0.01%	1332
2020 Q3	–	Sell	-5,735	Closed	-$1M	–	1244
2020 Q2	$1M	Buy	+5,735	New	+$915K	0.11%	215
2020 Q1	–	Sell	-1,946	Closed	-$297K	–	1026
2019 Q4	$297K	Buy	+1,946	New	+$269K	0.08%	233
2019 Q3	–	Sell	-934	Closed	-$133K	–	1057
2019 Q2	$133K	Buy	+934	New	+$127K	0.04%	423
2017 Q3	–	Sell	-141	Closed	-$14K	–	844
2017 Q2	$14K	Sell	141 -227	-62%	-$20.9K	0.01%	419
2017 Q1	$33K	Sell	368 -5,634	-94%	-$479K	0.04%	316
2016 Q4	$457K	Buy	+6,002	New	+$456K	0.46%	49
2016 Q1	–	Sell	-86	Closed	-$7K	–	533
2015 Q4	$7K	Buy	+86	New	+$6.2K	0.02%	311
2015 Q3	–	Sell	-1,388	Closed	-$98K	–	133
2015 Q2	$98K	Sell	1,388 -600	-30%	-$44.4K	0.19%	93
2015 Q1	$158K	Buy	1,988 +1,126	+131%	+$83.1K	0.14%	112
2014 Q4	$55K	Buy	862 +737	+590%	+$46.2K	0.05%	385
2014 Q3	$7K	Buy	+125	New	+$7.15K	﹤0.01%	317